Detalhe da pesquisa
1.
BCR-ABL1-positive chronic myeloid leukemia emerging in a patient with secondary myelofibrosis harboring the JAK2-V617F mutation.
Rinsho Ketsueki
; 58(4): 298-302, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-28484156
2.
Musculoskeletal pain after stopping tyrosine kinase inhibitor in patients with chronic myeloid leukemia: a questionnaire survey.
Rinsho Ketsueki
; 57(7): 873-6, 2016 07.
Artigo
em Japonês
| MEDLINE | ID: mdl-27498732
3.
[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib].
Rinsho Ketsueki
; 56(2): 216-9, 2015 Feb.
Artigo
em Japonês
| MEDLINE | ID: mdl-25765803
4.
BIM deletion polymorphism accounts for lack of favorable outcome in Japanese females with follicular lymphoma.
Leuk Lymphoma
; 60(5): 1283-1288, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30480474
5.
Synchronous diffuse large B-cell lymphoma and squamous cell lung carcinoma.
Respirol Case Rep
; 2(1): 33-5, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25473558